Globally, prosecutions for non‐disclosure, exposure or transmission of HIV frequently relate to sexual activity, biting, or spitting. This includes instances in which no harm was intended, HIV transmission did not occur, and HIV transmission was extremely unlikely or not possible. This suggests prosecutions are not always guided by the best available scientific and medical evidence.
Female, male, and transgender sex workers continue to have disproportionately high burdens of HIV infection in low-income, middle-income, and high-income countries in 2018. 4 years since our Lancet Series on HIV and sex work, our updated analysis of the global HIV burden among female sex workers shows that HIV prevalence is unacceptably high at 10·4% (95% CI 9·5–11·5) and is largely unchanged. Comprehensive epidemiological data on HIV and antiretroviral therapy (ART) coverage are scarce, particularly among transgender women.
Accelerating the Implementation and Scale-up of Comprehensive Programs for HIV Prevention, Diagnosis, Treatment and Care for Key Populations: LINKAGES Approach and Lessons Learned
In all countries where there is an HIV epidemic, certain subgroups of the population are at greater risk of HIV than others. These “key” populations include female sex workers (FSWs), men who have sex with men (MSM), transgender people, and people who inject drugs.
Pre-Exposure Prophylaxis (PrEP) for People Who Inject Drugs: Community voices on pros, cons, and concerns
This briefing paper outlines the results of a global consultation by the International Network of People who Use Drugs on PrEP. Approximately 75 people from 33 different countrires participated in the consultation.
Key findings of INPUD's consultation include: